ASH 2015 Data Promises Immunotherapy Revolution in Multiple Myeloma with Pembrolizumab

Frederic Reu, MD Taussig Cancer Institute, Department of Hematology & Medical Oncology Cleveland Clinic talks about new ASH 2015 Data That Promises Immunotherapy Revolution in Multiple Myeloma with Pembrolizumab